WS #12014
Holding: newest synthesis is 129d 1h old
FDA approves subcutaneous version of Biogen's Alzheimer's drug Leqembi for initiation and maintenance dosing, including at-home use.
Biogen Leqembi Approval
FDA approves subcutaneous version of Biogen's Alzheimer's drug Leqembi for initiation and maintenance dosing, including at-home use.